Northstack Northstack
  • Home
  • About
  • Research & Reports
  • Visiting Iceland?
  • Support
Sign in Subscribe

Oculis

Oculis raises an additional $15M in funding before going public

Oculis raises an additional $15M in funding before going public

The Iceland-founded biopharmaceutical company Oculis which is purposefully driven to save sight and improve eye care with innovations has raised $15M as first reported by Viðskiptablaðið. The participating investors in this newly secured funding round are from Iceland and abroad. This funding adds to the $80M that the company raised
Northstack Editorial Feb 6, 2023
Oculis raises $80M and goes public through a SPAC merger

Oculis raises $80M and goes public through a SPAC merger

Oculis, a global biopharmaceutical company founded by two Icelandic professors at the University of Iceland and European Biotech Acquisition Corp, a special purpose acquisition company (SPAC), have announced they have entered into a definitive business combination agreement. After this transaction, the company will be named “Oculis Holding SA” and will
Northstack Editorial Oct 18, 2022

Subscribe to Northstack

Sign up to receive updates straight to your inbox.
Northstack © 2023. Powered by Ghost